Juan C. Caravez

Juan C. Caravez

Auto-generated profile, based on publicly available information

Juan C. Caravez

Department of Chemistry and Biochemistry, University of California, Santa Barbara, CA, 93106, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 December 2022 in Organic Letters
Verified
Journal Article
Open access
JCJuan C. Caravez
Juan C. Caravez
KIKarthik S. Iyer
Karthik S. Iyer
RKRahul D. Kavthe
Rahul D. Kavthe
JKJoseph R. A. Kincaid
Joseph R. A. Kincaid
BLBruce Lipshutz
Bruce Lipshutz
A newly devised route to the Pfizer drug nirmatrelvir is reported that reduces the overall sequence to a 1-pot process and relies on a commercially available, green coupling reagent, T3P. The overall yield of the targeted material, isolated as its MTBE solvate, is 64%.

3 May 2022 in Organic Letters
Verified
Journal Article
Open access
JKJoseph R. A. Kincaid
Joseph R. A. Kincaid
RKRahul D. Kavthe
Rahul D. Kavthe
JCJuan C. Caravez
Juan C. Caravez
Balaram TakaleBalaram Takale
Balaram Takale
RTRuchita R. Thakore
Ruchita R. Thakore
BLBruce Lipshutz
Bruce Lipshutz
Two routes to the antimalarial drug Pyronaridine are described. The first is a linear sequence that includes a two-step, one-pot transformation in an aqueous surfactant medium, leading to an overall yield of 87%. Alternatively, a convergent route utilizes a telescoped three-step sequence involving an initial neat reaction, followed by two steps performed under aqueous micellar catalysis conditions affording Pyronaridine in 95% overall yield. Comparisons to existing literature performed exclusively in organic solvents reveal a 5-fold decrease in environmental impact as measured by E Factors.

26 May 2023 in Chemical Science
Verified
Journal Article
Open access
PDF file
RKRahul D. Kavthe
Rahul D. Kavthe
KIKarthik S. Iyer
Karthik S. Iyer
JCJuan C. Caravez
Juan C. Caravez
BLBruce Lipshutz
Bruce Lipshutz
A 6-step synthesis of the antimalarial drug candidate MMV688533 is reported.